ORI Updates

ORI released forecasts for two funding opportunity announcements (FOAs) for research integrity grants: Ensuring Research Integrity - Research, Development, and Demonstration; and Ensuring Research Integrity - Conferences.

ORI found that Stuart G. Jarrett, Ph.D. (Respondent), former research-track assistant professor, Department of Toxicology and Cancer Biology and Markey Cancer Center, University of Kentucky (UK) College of Medicine, engaged in research misconduct under 42 C.F.R. Part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), NIH, and National Institute of Environmental Health Sciences (NIEHS), NIH.

ORI found that Janina Jiang, M.D., Ph.D., former Assistant Researcher in the Department of Pathology & Laboratory Medicine at the David Geffen School of Medicine, University of California, Los Angeles (UCLA) engaged in research misconduct in research included in grant applications submitted for U.S. Public Health Service (PHS) funds, specifically the National Cancer Institute (NCI), National Institutes of Health (NIH), the National Center for Advancing Translational Sciences (NCATS), NIH, and the National Institute of Allergy and Infectious Diseases (NIAID), NIH.

ORI awarded three Ensuring Research Integrity- Research, Development, and Demonstration grants.

The Office of Research Integrity (ORI) is recruiting for a Senior Executive Service position to serve as the Director.

ORI found that Dr. Toni M. Brand, who was a graduate student in the Department of Human Oncology, UWM, and subsequently a research fellow in the Department of Otolaryngology - Head and Neck Surgery, UCSF, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), National Center for Research Resources (NCRR), NIH, National Center for Translational Sciences (NCATS), NIH, National Institute of General Medical Sciences (NIGMS), NIH, and National Institute of Dental and Craniofacial Research (NIDCR), NIH.

ORI has released its FY 2021 Annual Report, which highlights activities over the past year related to investigative oversight, communications, ORI’s grant program, ORI intramural projects, and ORI’s compliance programs.

ORI found that Hui (Herb) Bin Sun, Ph.D., formerly Professor of Orthopedic Surgery and Radiation Oncology, AECM, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), and National Heart, Lung, and Blood Institute (NHLBI), NIH.

ORI found that Daniel Leong, Ph.D., formerly a Research Technician, AECM, engaged in research misconduct in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), and National Heart, Lung, and Blood Institute (NHLBI), NIH.

In calendar year 2021 (CY21), ORI closed 93 cases. This includes 3 cases with research misconduct findings, 26 cases in which ORI declined to pursue (DTP), 12 cases without findings of research misconduct (no-misconduct), and 52 cases closed during the assessment or inquiry stage (accession closure).